TNF and inflammatory bowel disease: Fourthly, as the study population comprised only five patients with anti-TNF-therapy-induced LCV, the results cannot be generalized to the wider population, especially in terms of the optimal therapeutic strategies for use in patients with IBD-associated vasculitis.